Targeted delivery of methotrexate to tumor cells using biotin functionalized methotrexate-human serum albumin conjugated nanoparticles

Journal of Biomedical Nanotechnology

Volumn 7, Issue 6, 2011, Pages 743-753

  Taheri, Azade ^a   Dinarvand, Rassoul ^a   Atyabi, Fatemeh ^a   Nouri, Faranak ^a   Ahadi, Fatemeh ^a   Ghahremani, Mohammad Hossein ^a   Ostad, Seyed Nasser ^a   Borougeni, Atefeh Taheri ^b   Mansoori, Pooria ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biotin; Cancer; Human serum albumin; Methotrexate; Nanoparticles; Targeted drug delivery

Indexed keywords

BIOTIN; CANCER; HUMAN SERUM ALBUMINS; METHOTREXATE; TARGETED DRUG DELIVERY;

CHEMOTHERAPY; COENZYMES; DISEASES; DRUG DELIVERY; FLOW CYTOMETRY; TOXICITY; TUMORS;

NANOPARTICLES;

BIOTIN; FLUORESCEIN ISOTHIOCYANATE; HUMAN SERUM ALBUMIN; METHOTREXATE; NANOPARTICLE;

ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG STRUCTURE; DRUG UPTAKE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; SURFACE PROPERTY; TUMOR CELL;

ANTINEOPLASTIC AGENTS; BIOTIN; CELL SURVIVAL; DRUG STABILITY; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; METHOTREXATE; MICROSCOPY, FLUORESCENCE; NANOCONJUGATES; PARTICLE SIZE; SERUM ALBUMIN;

EID: 84856895394     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2011.1340     Document Type: Article

References (41)

1. T. Tanaka, P. Decuzzi, M. Cristofanilli, S. Jason, H. E. Tasciotti, F. M. Robertson, and M. Ferrari, Nanotechnology for breast cancer therapy. Biomed. Microdevices 11, 49 (2009).
2. T. M. Allen, E. Brandeis, C. B. Hansen, G. Y. Kao, and S. Zaplipsky, A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim. Biophys. Acta 1237, 99 (1995).
3. S. Jaracs, J. Chen, K. Larisa, and I. Ojima, Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med. Chem. 13, 5043 (2005).
4. P. Wu, X. He, K. Wang, W. Tan, C. He, and M. Zheng, A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles. J. Biomed. Nanotechnol. 5, 557 (2009).
5. U. Mukesh,V. Kulkarni, R. Tushar, and R. S. R. Murthy, Methotrexate loaded self stabilized calcium phosphate nanoparticles: A novel inorganic carrier for intracellular drug delivery. J. Biomed. Nanotechnol. 5, 99 (2009).
6. D. Liu, L. Wang, Z. Liu, C. Zhang, and N. Zhang, Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery. J. Biomed. Nanotechnol. 6, 675 (2010).
7. O. M. Koo, I. Rubinstein, and H. Onyuksel, Role of nanotechnology in targeted drug delivery and imaging: A concise review. Nanomedicine 1, 193 (2005).
8. Y. Cao, Y. Gub, H. Maa, J. Bai, L. Liua, P. Zhaoa, and H. He, Self-assembled nanoparticle drug delivery systems from galactosylated polysaccharide-doxorubicin conjugate loaded doxorubicin. Int. J. Biol. Macromol. 46, 245 (2010).
9. M. R. Saboktakina, R. M. Tabatabaiea, A. Maharramovb, and M. A. Ramazanov, Development and in vitro evaluation of thiolated chitosan-Poly (methacrylicacid) nanoparticles as a local mucoadhesive delivery system. Int. J. Biol. Macromole. 48, 403 (2011).
10. J. J. Khandare, P. Chandna, Y. Wang, V. P. Pozharov, and T. Minko, Novel polymeric prodrug with multivalent components for cancer therapy. J. Pharmacol. Exp. Ther. 317, 929 (2006).
11. K. Cho, X. Wang, S. Nie, Z. Chen, and D. M. Shin, Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 14, 1310 (2008).
12. S. Rai, R. Paliwal, and S. P. Vyas, Doxorubicin encapsulated nanocarriers for targeted delivery to estrogen responsive breast cancer. J. Biomed. Nanotechnol. 7, 121 (2011).
13. D. Singodia, S. Talegaonkar, R. K. Khar, and P. R. Mishra, Novel polymer coupled lipid nanoparticle of paclitaxel with synergistic enhanced efficacy against cancer. J. Biomed. Nanotechnol. 7, 125 (2011).
14. R. Paliwal, S. Rai, and S. P. Vyas, Lipid drug conjugate (LDC) nanoparticles as autolymphotrophs for oral delivery of methotrexate. J. Biomed. Nanotechnol. 7, 130 (2011).
15. I. Steinhauser, B. Spankuchb, K. Strebhardt, and L. Klaus, Trastuzumab modified nanoparticles: Optimisation of preparation and uptake in cancer cells. Biomaterials 27, 4975 (2006).
16. M. G. Anhorn, S. Wagner, J. Kreuter, K. Langer, and H. Briesen, Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles. Bioconjugate Chem. 19, 2321 (2008).
17. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J. Control. Release 65, 271 (2000).
18. Y. Matsumura and H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387 (1986).
19. F. Esmaeili, R. Dinarvand, M. H. Ghahremani, M. Amini, H. Rouhani, N. Sepehri, S. N. Ostad, and F. Atyabi, Docetaxel-albumin conjugates: Preparation, in vitro evaluation and biodistribution studies. J. Pharm. Sci. 98, 2718 (2009).
20. A. Taheri, F. Atyabi, F. Salman Nouri, F. Ahadi, M. A. Derakhshan, M. Amini, M. Ghahremani, S. N. Ostad, P. Mansoori, and R. Dinarvand, Nanoparticles of conjugated methotrexate-human serum albumin: Preparation and cytotoxicity evaluations. J. Nanomaterials (2011).
21. D. M. Mock, E. E. Ziegler, and L. J. Filer (eds.), Present Knowledge in Nutrition, 7th edn., Washington, DC: ILSI Press (1996).
22. Y. Patil, T. Sadhukha, L. Ma, and J. Panyam, Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. J. Control. Release 36, 21 (2009).
23. W. Yang, Y. Cheng, T. Xu, X. Wang, and L. P. Wen, Targeting cancer cells with biotin dendrimer conjugates. Eur. J. Med. Chem. 44, 862 (2009).
24. K. Na, Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. Eur. J. Pharm. Sci. 18, 165 (2003).
25. N. C. Green, A spectrophotometric assay for avidin and biotin based on binding of dyes by avidin. Biochem. J. 94, 23C (1965).
26. N. Anande, S. Jain, and N. Jain, Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate. Int. J. Pharm. 359, 182 (2008).
27. G. Yousffi, S. M. Foroutan, A. Zarghi, and A. Shafaati, Synthesis and characterization of methotrexate polyethylene glycol esters as a drug delivery system. Chem. Pharm. Bull. 58, 147 (2010).
28. R. Goyal, S. K. Tripathi, S. Tyagi, K. Ravi Ram, K. M. Ansari, P. Kumar, Y. Shukla, D. Kar Chowdhuri, and K. C. Gupta, Gellan gum-PEI nanocomposites as efficient gene delivery agents. J. Biomed. Nanotechnol. 7, 38 (2011).
29. V. Pokharkar, D. Bhumkar, K. Suresh, Y. Shinde, S. Gairola, and S. S. Jadhav, Gold nanoparticles as a potential carrier for transmucosal vaccine delivery. J. Biomed. Nanotechnol. 7, 57 (2011).
30. S. Malathi and S. Balasubramanian, Synthesis of biodegradable polymeric nanoparticles and their controlled drug delivery for tuberculosis. J. Biomed. Nanotechnol. 7, 150 (2011).
31. J. Fu, D. Wang, T. Wang, W. Yang, Y. Deng, H. Wang, S. Jin, and N. He, High entrapment efficiency of chitosan/polylactic acid/tripolyphotspate nanosized microcapsules for rapamycin by an emulsion-evaporation approach. J. Biomed. Nanotechnol. 6, 725 (2010).
32. M. Sun, Y. Gao, Y. Pei, C. Guo, H. Li, F. Cao, A. Yu, and G. Zhai, Development of nanosuspension formulation for oral delivery of quercetin. J. Biomed. Nanotechnol. 6, 325 (2010).
33. P. Blasi, A. Schoubben, S. Giovagnoli, C. Rossi, and M. Ricci, Lipid nanoparticles for drug delivery to the brain: In vivo veritas. J. Biomed. Nanotechnol. 5, 344 (2009).
34. M. J. Hawkins, P. Soon-Shiong, and N. Desai, Protein nanoparticles as drug carriers in clinical medicine. Adv. Drug Deliv. Rev. 60, 876 (2008).
35. F. Kratz, Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J. Control. Release 132, 171 (2008).
36. K. Michaelis, M. M. Hoffmann, S. Dreis, E. Herbert, R. N. Alyautdin, M. Michaelis, J. Kreuter, and K. Lange, Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain. JPET 317, 1246 (2006).
37. L. Zhang, S. Hou, S. Mao, D. Wei, X. Song, and Y. Lu, Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells. Int. J. Pharm. 287, 155 (2004).
38. S. Y. Kim, S. H. Cho, M. L. Young, and L. Y. Chu, Biotin-conjugated block copolymeric nanoparticles as tumor-targeted drug delivery systems. Macromol. Res. 15, 646 (2007).
39. T. Minko, M. L. Patil, M. Zhang, J. J. Khandare, M. Saad, P. Chandna, and O. Taratula, LHRH-targeted nanoparticles for cancer therapeutics. Methods. Mol. Biol. 624, 281 (2010).
40. S. Wagner, F. Rothweiler, M. G. Anhorn, D. Sauer, I. Riemann, E. C. Weiss, A. Katsen-Globa, M. Michaelis, J. C. Jr, and D. Schwartz, Enhanced drug targeting by attachment of an anti av integrin antibody to doxorubicin loaded human serum albumin nanoparticles. Biomaterials 31, 2388 (2010).
41. S. K. Sahoo, J. Panyam, S. Prabha, and V. Labhasetwar, Residual polyvinyl alcohol associated with poly(D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control. Release 82, 105 (2002).